Liquid Biopsy Using Methylation Sequencing for Lung Cancer

CompletedOBSERVATIONAL
Enrollment

280

Participants

Timeline

Start Date

February 3, 2020

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
Lung CancerDiagnoses Disease
Interventions
DIAGNOSTIC_TEST

Circulating Tumor DNA Methylation Sequencing

Whole blood (21mL) collection through venipuncture. Analysis of tumor markers and ctDNA methylation sequencing.

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

EDGC Inc.

UNKNOWN

lead

Samsung Medical Center

OTHER

NCT04253509 - Liquid Biopsy Using Methylation Sequencing for Lung Cancer | Biotech Hunter | Biotech Hunter